BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

32 related articles for article (PubMed ID: 1942543)

  • 1. First platelet transfusion refractoriness in a patient with acute myelocytic leukemia: A case report.
    Tu SK; Fan HJ; Shi ZW; Li XL; Li M; Song K
    World J Clin Cases; 2023 Oct; 11(29):7156-7161. PubMed ID: 37946754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A commentary on the optimal red blood cell transfusion threshold in acute leukemia patients.
    Asante A; Nguyen PL; Blumberg N
    Blood Transfus; 2023 Nov; 21(6):461-462. PubMed ID: 37677098
    [No Abstract]   [Full Text] [Related]  

  • 3. First-line MAPK inhibition in pediatric histiocytosis: are we ready?
    Abla O
    Haematologica; 2024 Apr; 109(4):1029-1031. PubMed ID: 37981827
    [No Abstract]   [Full Text] [Related]  

  • 4. Bone marrow transplantation for advanced acute leukemia: a pilot study of high-energy total body irradiation, cyclophosphamide and continuous infusion etoposide.
    Bostrom B; Weisdorf DJ; Kim T; Kersey JH; Ramsay NK
    Bone Marrow Transplant; 1990 Feb; 5(2):83-9. PubMed ID: 2107007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spontaneous complete remission in a child with acute lymphoblastic leukemia.
    Yetgin S; Tuncer AM; Güler E; Ozbek N
    Turk J Pediatr; 1996; 38(2):227-9. PubMed ID: 8701489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeuticefficacy of platelet transfusion in patients with acute leukemia.
    Valeri CR; Ragno G
    Transfusion; 2010 Nov; 50(11):2504; author reply 2505-6. PubMed ID: 21182633
    [No Abstract]   [Full Text] [Related]  

  • 7. Allogeneic stem-cell transplantation in patients with refractory acute leukemia: a long-term follow-up.
    Oyekunle AA; Kröger N; Zabelina T; Ayuk F; Schieder H; Renges H; Fehse N; Waschke O; Fehse B; Kabisch H; Zander AR
    Bone Marrow Transplant; 2006 Jan; 37(1):45-50. PubMed ID: 16258531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effectiveness of etoposide on reactive histiocytosis and refractory state to platelet transfusion during therapy of leukemia: case report].
    Ishida Y; Yokota Y; Tauchi H; Matusda H
    Rinsho Ketsueki; 1991 Sep; 32(9):970-5. PubMed ID: 1942543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Etoposide ameliorated refractory hemophagocytic syndrome in a patient with systemic sclerosis].
    Katsumata Y; Okamoto H; Harigai M; Ota S; Uesato M; Tochimoto A; Kawaguchi Y; Terai C; Hara M; Kamatani N
    Ryumachi; 2002 Oct; 42(5):820-6. PubMed ID: 12462023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occurrence of acute nonlymphoblastic leukemia in two girls after treatment of recurrent, disseminated Langerhans cell histiocytosis.
    Kager L; Heise A; Minkov M; Möbius D; Kotte W; Schulte-Overberg U; Henze G; Gadner H
    Pediatr Hematol Oncol; 1999; 16(3):251-6. PubMed ID: 10326224
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.